Treatment of Overweight Children and Adolescents

This study has been completed.
Sponsor:
Collaborator:
University of Bremen
Information provided by:
University of Witten/Herdecke
ClinicalTrials.gov Identifier:
NCT00422916
First received: January 16, 2007
Last updated: January 10, 2012
Last verified: February 2009
  Purpose

The intervention program "Obeldicks light" is developed for overweight children aged 8-16 years. This intervention is gender - and age specific.

The 6-month intervention is based on nutrition course, behaviour therapy and exercise therapy. The evaluation compromised quality of structure, process and results of the intervention. 300 participants in a randomised controlled group design will be evaluated at 4 time points: baseline, end of intervention, 6 months after end of intervention and 12 months after end of intervention.Primary outcome measure is change of weight status as standard deviation score of BMI. Drop-outs will be interviewed to improve the intervention.


Condition Intervention
Overweight
Behavioral: behavioral intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Evaluation of the Intervention Program "Obeldicks Light" for Overweight Children and Adolescents

Further study details as provided by University of Witten/Herdecke:

Primary Outcome Measures:
  • change of weight status

Secondary Outcome Measures:
  • Change of eating and exercise behaviour
  • change of quality of life

Enrollment: 66
Study Start Date: January 2007
Study Completion Date: December 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   8 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • overweight children

Exclusion Criteria:

  • primary disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00422916

Locations
Germany
Vestische Youth Hospital
Datteln, Germany, 45711
Sponsors and Collaborators
University of Witten/Herdecke
University of Bremen
Investigators
Study Chair: Petra Kolip, Prof University of Bremen, Germany